Skip to content

Het effect van de inname van een vleesvervanger op spieropbouw in jongere mannen

The anabolic response following ingestion of a plant-based protein product in vivo in healthy young men

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20986
Enrollment
24
Registered
2017-04-25
Start date
2017-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle protein metabolism

Interventions

Subjects will either consume 40 g plantbased or animal protein (isonitrogenous amount) in the form of a ready-to-eat product (n = 12 per group).

Sponsors

Maastricht University Medical Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Males • Aged between 18 - 35 years • Healthy, recreationally active (max 3 days per week performing activities) • BMI 18.5 – 27.5 kg/m2

Exclusion criteria

Exclusion criteria: • Females • Diagnosed diabetes • Wheat allergy • Celiac disease • Smoking • Diagnosed metabolic or intestinal disorders • A history of neuromuscular problems • Any medications known to (or may) affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications). • Participation in structured resistance exercise program • Previous participation in a 13C amino acid tracer study within the last year

Design outcomes

Primary

MeasureTime frame
Primary study parameters include myofibrillar protein synthesis rates, expressed as FSR (%/h), using muscle-protein bound L-[ring-13C6]-phenylalanine enrichments and muscle tissue-free and plasma L-[ring-13C6]-phenylalanine enrichments as precursor.

Secondary

MeasureTime frame
Secondary endpoints will be plasma amino acid concentrations (total amino acid profile), glucose, and insulin concentrations.

Contacts

Public ContactL.J.C. Loon, van

Capaciteitsgroep Human Biology, room 2.356, Universiteitssingel 50

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)